Cancer types

Lung Cancer

Including NSCLC and SCLC. 98 official records currently indexed across three regions.

Trial records retrieved live from the ClinicalTrials.gov public API.

Open to enrolment onlyAdvanced / later-line records onlyPhaseSort byShowing 98 of 98

Highlight terms:

Build a discussion list0 selected

Select the public official records you want to take to your appointment, then generate a list. Nothing is ranked or recommended — the list only reproduces titles and links.

Not signed in — up to 5 records per list. Sign in for higher free limits, or see Pro for more exports.

USClinicalTrials.gov【Trial record】

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Phase 1RecruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Phase 1/2RecruitingSource updated: Oct 1, 2026

Select this record

View original

USEUCNOTHERClinicalTrials.gov【Trial record】

A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

Phase 1/2RecruitingSource updated: Oct 1, 2026

Select this record

View original

USEUCNOTHERClinicalTrials.gov【Trial record】

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

Phase 3RecruitingSource updated: Oct 1, 2026

Select this record

View original

USEUCNOTHERClinicalTrials.gov【Trial record】

A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

Phase 3RecruitingSource updated: Oct 1, 2026

Select this record

View original

USEUCNOTHERClinicalTrials.gov【Trial record】

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Phase 3Active, not recruitingSource updated: Oct 1, 2026

Select this record

View original

USCNClinicalTrials.gov【Trial record】

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 2RecruitingSource updated: Oct 1, 2026

Select this record

View original

USEUOTHERClinicalTrials.gov【Trial record】

A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

Phase 1/2RecruitingSource updated: Oct 1, 2026

Select this record

View original

USEUCNOTHERClinicalTrials.gov【Trial record】

A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)

Phase 2RecruitingSource updated: Oct 1, 2026

Select this record

View original

USEUOTHERClinicalTrials.gov【Trial record】

A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)

Phase 2RecruitingSource updated: Oct 1, 2026

Select this record

View original

USEUCNOTHERClinicalTrials.gov【Trial record】

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Phase 1RecruitingSource updated: Oct 1, 2026

Select this record

View original

EUClinicalTrials.gov【Trial record】

AI-Assisted 3D Reconstruction for Lung Resection Planning

Not yet recruitingSource updated: Oct 1, 2026

Select this record

View original

USEUCNOTHERClinicalTrials.gov【Trial record】

Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment

Phase 3Active, not recruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer

Phase 2RecruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Phase 3RecruitingSource updated: Oct 1, 2026

Select this record

View original

OTHERClinicalTrials.gov【Trial record】

Early Prophylactic Versus Late Salvage Recombinant Human Endostatin in Managing Radiosurgery-Induced Brain Injury for NSCLC Brain Metastases

Phase 2Not yet recruitingSource updated: Oct 1, 2026

Select this record

View original

OTHERClinicalTrials.gov【Trial record】

Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism

Phase 4Not yet recruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Empathic Communication Skills (ECS) Training

Not applicableRecruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Phase 2Active, not recruitingSource updated: Oct 1, 2026

Select this record

View original

USOTHERClinicalTrials.gov【Trial record】

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Not applicableActive, not recruitingSource updated: Oct 1, 2026

Select this record

View original

EUClinicalTrials.gov【Trial record】

HTL0039732 in Participants With Advanced Solid Tumours

Phase 1/2RecruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Phase 3RecruitingSource updated: Oct 1, 2026

Select this record

View original

EUClinicalTrials.gov【Trial record】

Integrating Artificial Intelligence Into Lung Cancer Screening.

Not applicableRecruitingSource updated: Oct 1, 2026

Select this record

View original

EUCNOTHERClinicalTrials.gov【Trial record】

MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)

Phase 3RecruitingSource updated: Oct 1, 2026

Select this record

View original

USOTHERClinicalTrials.gov【Trial record】

NCI COVID-19 in Cancer Patients, NCCAPS Study

Active, not recruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Phase 3RecruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Phase 2RecruitingSource updated: Oct 1, 2026

Select this record

View original

OTHERClinicalTrials.gov【Trial record】

Radiomics for Distinguishing Benign and Malignant Lung Nodules

Not yet recruitingSource updated: Oct 1, 2026

Select this record

View original

EUCNOTHERClinicalTrials.gov【Trial record】

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

Phase 1/2RecruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

SBRT for Ultra-Central NonSmall Cell Lung Cancer

Phase 1Not yet recruitingSource updated: Oct 1, 2026

Select this record

View original

USEUOTHERClinicalTrials.gov【Trial record】

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Phase 1RecruitingSource updated: Oct 1, 2026

Select this record

View original

OTHERClinicalTrials.gov【Trial record】

Symptoms, Physical Function, and Recovery in Patients Receiving Lung Cancer Treatment Before Surgery

Not yet recruitingSource updated: Oct 1, 2026

Select this record

View original

USOTHERClinicalTrials.gov【Trial record】

Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Phase 3Active, not recruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

Phase 2/3Active, not recruitingSource updated: Oct 1, 2026

Select this record

View original

USOTHERClinicalTrials.gov【Trial record】

Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

Phase 3Active, not recruitingSource updated: Oct 1, 2026

Select this record

View original

OTHERClinicalTrials.gov【Trial record】

TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors

Phase 1RecruitingSource updated: Oct 1, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

Phase 3RecruitingSource updated: Aug 14, 2026

Select this record

View original

OTHERClinicalTrials.gov【Trial record】

A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)

Phase 2RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Phase 3RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

A Study of Lung Cancer Risk

RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Phase 2RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Phase 3RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

Phase 3RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Phase 3RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer

Phase 2RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

Phase 1RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

Phase 2RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease

Phase 1Not yet recruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

Phase 1Active, not recruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Clinical Genetics Branch Eligibility Screening Survey

Not yet recruitingSource updated: Aug 14, 2026

Select this record

View original

CNClinicalTrials.gov【Trial record】

Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 Insertion

Phase 2Active, not recruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Esomeprazole and Radiation Induced Esophagitis

Phase 2RecruitingSource updated: Aug 14, 2026

Select this record

View original

OTHERClinicalTrials.gov【Trial record】

Feasibility and Uptake of Low-Dose CT Lung Cancer Screening in Kuwait

Not applicableNot yet recruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer

Phase 2RecruitingSource updated: Aug 14, 2026

Select this record

View original

OTHERClinicalTrials.gov【Trial record】

Post-operative Radiotherapy After Neodjuvant Chemo-immunotherapy and Surgery in Stage III NSCLC

Phase 2RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

Phase 3Active, not recruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Phase 1/2RecruitingSource updated: Aug 14, 2026

Select this record

View original

OTHERClinicalTrials.gov【Trial record】

Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot Study

Phase 1Not yet recruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Phase 3RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Phase 3RecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

The Vanguard Study: Testing a New Way to Screen for Cancer

Not applicableRecruitingSource updated: Aug 14, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)

Phase 2Active, not recruitingSource updated: Aug 14, 2026

Select this record

View original

CNClinicalTrials.gov【Trial record】

A Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases

Phase 3RecruitingSource updated: Aug 13, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies

Phase 1Active, not recruitingSource updated: Aug 13, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer

Phase 1/2Active, not recruitingSource updated: Aug 13, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Collection of Blood From Patients With Cancer

RecruitingSource updated: Aug 13, 2026

Select this record

View original

OTHERClinicalTrials.gov【Trial record】

ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI)

Phase 2Not yet recruitingSource updated: Aug 13, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

Not applicableRecruitingSource updated: Aug 13, 2026

Select this record

View original

CNClinicalTrials.gov【Trial record】

Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer

Phase 3RecruitingSource updated: Aug 13, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Harvesting Cells for Experimental Cancer Treatments

Enrolling by invitationSource updated: Aug 13, 2026

Select this record

View original

CNClinicalTrials.gov【Trial record】

JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C Mutation

Phase 3RecruitingSource updated: Aug 13, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer

Phase 1Active, not recruitingSource updated: Aug 13, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Phase 2/3RecruitingSource updated: Aug 13, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

Phase 2RecruitingSource updated: Aug 13, 2026

Select this record

View original

USClinicalTrials.gov【Trial record】

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

Phase 2RecruitingSource updated: Aug 13, 2026

Select this record

View original

CNClinicalTrials.gov【Trial record】

To Assess the Efficacy and Safety of Furmonertinib Versus Placebo, in Patients With Epidermal Growth Factor Receptor Mutation Positive Stage II-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy

Phase 3RecruitingSource updated: Aug 13, 2026

Select this record

View original

CNCDE【Guideline / public regulatory information】

CDE 临床试验默示许可 — clinical trial implied licence notices

Index verified: Aug 16, 2026

Select this record

View original

CNCDE【Guideline / public regulatory information】

CDE 优先审评公示 — priority review listings

Index verified: Aug 16, 2026

Select this record

View original

CNCDE【Guideline / public regulatory information】

CDE 受理品种信息 — applications accepted for review

Index verified: Aug 16, 2026

Select this record

View original

CNCDE【Guideline / public regulatory information】

CDE 指导原则 — published technical guidance documents

Index verified: Aug 16, 2026

Select this record

View original

CNCDE【Guideline / public regulatory information】

CDE 突破性治疗公示 — breakthrough therapy designation notices

Index verified: Aug 16, 2026

Select this record

View original

CNCDE【Guideline / public regulatory information】

CDE 附条件批准品种 — conditionally approved products list

Index verified: Aug 16, 2026

Select this record

View original

CNChiCTR【Guideline / public regulatory information】

ChiCTR — Chinese Clinical Trial Registry, public search

Index verified: Aug 16, 2026

Select this record

View original

EUCTIS【Guideline / public regulatory information】

CTIS public register — search clinical trials authorised in the EU/EEA

Index verified: Aug 16, 2026

Select this record

View original

EUEMA【Guideline / public regulatory information】

EMA — CHMP meeting highlights and opinions on new medicines

Index verified: Aug 16, 2026

Select this record

View original

EUEMA【Guideline / public regulatory information】

EMA — medicines for human use currently under evaluation (monthly CHMP list)

Index verified: Aug 16, 2026

Select this record

View original

EUEMA【Guideline / public regulatory information】

EMA — searchable database of authorised medicines in the EU

Index verified: Aug 16, 2026

Select this record

View original

EUESMO【Guideline / public regulatory information】

ESMO Clinical Practice Guidelines — lung and chest tumours

Index verified: Aug 16, 2026

Select this record

View original

EUESMO【Guideline / public regulatory information】

ESMO Clinical Practice Guidelines — public index by tumour type

Index verified: Aug 16, 2026

Select this record

View original

EUESMO【Guideline / public regulatory information】

ESMO Clinical Practice Guidelines — supportive and palliative care section

Index verified: Aug 16, 2026

Select this record

View original

USFDA【Guideline / public regulatory information】

FDA — expanded access (compassionate use) information for patients

Index verified: Aug 16, 2026

Select this record

View original

USFDA【Guideline / public regulatory information】

FDA — oncology (cancer) / hematologic malignancies approval notifications

Index verified: Aug 16, 2026

Select this record

View original

USFDA【Guideline / public regulatory information】

FDA — ongoing accelerated approvals for oncology indications

Index verified: Aug 16, 2026

Select this record

View original

USNCCN【Guideline / public regulatory information】

NCCN Guidelines — palliative care category listing

Index verified: Aug 16, 2026

Select this record

View original

USNCCN【Guideline / public regulatory information】

NCCN Guidelines — public index by cancer type (free registration)

Index verified: Aug 16, 2026

Select this record

View original

USNCCN【Guideline / public regulatory information】

NCCN Guidelines for Patients — plain-language versions

Index verified: Aug 16, 2026

Select this record

View original

CNNMPA【Guideline / public regulatory information】

NMPA 药品 — national drug approval announcements

Index verified: Aug 16, 2026

Select this record

View original

CNCDE【Guideline / public regulatory information】

药物临床试验登记与信息公示平台 — national registry of drug trials conducted in China

Index verified: Aug 16, 2026

Select this record

View original